Net Income - Bergenbio ASA (OSE:BGBIO) - Alpha Spread
B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 9.07 NOK 1.06% Market Closed
Market Cap: 368.3m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bergenbio ASA
Net Income Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Net Income
-kr154.5m
CAGR 3-Years
19%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Net Income
-kr97.9m
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
-9%
L
Lytix Biopharma AS
OSE:LYTIX
Net Income
-kr87.9m
CAGR 3-Years
-28%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Net Income
kr22.6m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Net Income
-$48.5m
CAGR 3-Years
N/A
CAGR 5-Years
-41%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Net Income
-kr5.6m
CAGR 3-Years
76%
CAGR 5-Years
56%
CAGR 10-Years
11%

See Also

What is Bergenbio ASA's Net Income?
Net Income
-154.5m NOK

Based on the financial report for Mar 31, 2024, Bergenbio ASA's Net Income amounts to -154.5m NOK.

What is Bergenbio ASA's Net Income growth rate?
Net Income CAGR 5Y
3%

Over the last year, the Net Income growth was 47%. The average annual Net Income growth rates for Bergenbio ASA have been 19% over the past three years , 3% over the past five years .

Back to Top